Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia

Clinical trial NCT00040105 · COMPLETED

Trial details

NCT number: NCT00040105
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid, Chronic

Start date: 2002-10-01
Primary completion: 2009-03-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.